Diagnosis Tools
The diagnosis section will provide you with a range of both downloadable and online tools, to enable you to quickly identify and accurately assess patients at risk of CVD.
The diagnosis section will provide you with a range of both downloadable and online tools, to enable you to quickly identify and accurately assess patients at risk of CVD.
Treatment Tools
There are a number of treatment strategies that can be employed to minimise the risk of a cardiovascular event in patients diagnosed with CVD. The treatment section will provide you with the tools you need, to allow you to confidently decide upon the most appropriate treatment strategy for your patients.
There are a number of treatment strategies that can be employed to minimise the risk of a cardiovascular event in patients diagnosed with CVD. The treatment section will provide you with the tools you need, to allow you to confidently decide upon the most appropriate treatment strategy for your patients.
Patient Tools
It is important to encourage patients to get involved in keeping their heart healthy. Lifestyle changes as well as treatment adherence are necessary to maximise clinical benefits. The various tools in the patient section will provide you with a series of materials that will:
It is important to encourage patients to get involved in keeping their heart healthy. Lifestyle changes as well as treatment adherence are necessary to maximise clinical benefits. The various tools in the patient section will provide you with a series of materials that will:
- Enable you to interact with your patients and monitor their progress
- Enable your patients to take part ownership of their treatment, thereby keeping them engaged
Clinical Tools
The Cholesterol Knowledge Centre also has links to the most recently published clinical research, guidelines and recommendations, so that you can keep up-to-date with the latest findings in cardiovascular medicine.
The Cholesterol Knowledge Centre also has links to the most recently published clinical research, guidelines and recommendations, so that you can keep up-to-date with the latest findings in cardiovascular medicine.
Resources to assist management of your patients with cardiovascular disease
Cardiovascular disease (CVD) is the primary cause of death worldwide.1 It is vital that patients at risk of CVD are identified and appropriately treated to prevent future cardiovascular events. However, detection of those at risk of a cardiovascular event can be problematic because there are often no underlying symptoms. According to the American Heart Association (2009); 50% of men and 64% of women who died suddenly of coronary heart disease had no previous symptoms.2,3
The EUROASPIRE III study was conducted to evaluate cardiovascular health and its management – including blood pressure, lipid profile and lifestyle factors – in Europe. The investigators concluded that despite considerable improvement from previous surveys, lipid treatment goals were not being achieved in a substantial proportion (42.7%) of patients receiving lipid-lowering treatment.4
The ultimate goal of lipid-lowering therapy is cardiovascular event reduction, and the Cholesterol Knowledge Centre provides you with a wide range of resources to help you with your management strategy for CVD.
References:
1. World Health Organization (WHO). Cardiovascular diseases. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/index.html [Accessed 12/11/2009]
2. American Heart Association. Women and Cardiovascular Diseases – Statistics 2009. Available at: http://www.americanheart.org/downloadable/heart/1236184538758WOMEN.pdf
3. American Heart Association. Men and Cardiovascular Diseases – Statistics 2009. Available at: http://www.americanheart.org/downloadable/heart/1237141547637MEN.pdf
4. Kotseva K et al. Lancet 2009; 373:929–940.
Cardiovascular disease (CVD) is the primary cause of death worldwide.1 It is vital that patients at risk of CVD are identified and appropriately treated to prevent future cardiovascular events. However, detection of those at risk of a cardiovascular event can be problematic because there are often no underlying symptoms. According to the American Heart Association (2009); 50% of men and 64% of women who died suddenly of coronary heart disease had no previous symptoms.2,3
The EUROASPIRE III study was conducted to evaluate cardiovascular health and its management – including blood pressure, lipid profile and lifestyle factors – in Europe. The investigators concluded that despite considerable improvement from previous surveys, lipid treatment goals were not being achieved in a substantial proportion (42.7%) of patients receiving lipid-lowering treatment.4
The ultimate goal of lipid-lowering therapy is cardiovascular event reduction, and the Cholesterol Knowledge Centre provides you with a wide range of resources to help you with your management strategy for CVD.
References:
1. World Health Organization (WHO). Cardiovascular diseases. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/index.html [Accessed 12/11/2009]
2. American Heart Association. Women and Cardiovascular Diseases – Statistics 2009. Available at: http://www.americanheart.org/downloadable/heart/1236184538758WOMEN.pdf
3. American Heart Association. Men and Cardiovascular Diseases – Statistics 2009. Available at: http://www.americanheart.org/downloadable/heart/1237141547637MEN.pdf
4. Kotseva K et al. Lancet 2009; 373:929–940.